China securities regulator approves CXMT IPO, setting up Shanghai STAR Market listing

Chengxin Memory Technology, known as CXMT, received final approval to proceed with an initial public offering in Shanghai, clearing the way for what a report described as the biggest mainland stock market listing since 2022. The approval was granted by China’s securities watchdog, the report said, after the company’s registration for the offering advanced through the approval process.

CXMT is described as a leading maker of DRAM, or dynamic random-access memory, chips. The report said its IPO registration on Shanghai’s Nasdaq-style STAR Market became the subject of final review by the regulator, and that the latest clearance completes the company’s path to launch a mainland listing.

The STAR Market is where Chinese technology and emerging-growth firms have sought to raise capital, and the report characterized the proposed offering as a major event for the domestic IPO calendar. The same report framed the clearance as a sign that IPO approvals on the mainland have continued despite a slowdown that had kept large listings from returning at scale since 2022.

The approval also has practical implications for market timing and corporate funding. Once an issuer has final regulatory clearance, it can move toward determining pricing and completing the remaining steps needed to sell shares to investors, a process that typically affects both company cash planning and market participation during the listing window, according to standard IPO mechanics.

The report did not provide deal size, pricing, or a specific launch date in the information available for this draft. It also did not specify the regulator’s formal action documents, such as the issuance of an approval notice or the exact date of the clearance, beyond describing that the registration for the IPO had reached final approval.

No additional primary documents were located in the available research. Because the central claim in this story depends on the regulator approval described in the reporting, publication may require confirmation from an official China securities-regulator filing or the company’s disclosure to ensure key details such as timing, offer structure, and terms are accurate.